GHD.jpg

GHD

Medical homecare products and services

GHD is the market leading homecare provider in Germany, delivering medical products, advice and services to more than 140,000 patients. The company operates in the German healthcare market, which is characterised by positive long-term demand driven by demographic trends.

Company Background

  • Longstanding expertise with 30 years in the German healthcare market
  • Intergated business model that combines the production of medical supplies and compounded pharmaceuticals with strong wholesale and logistics activities
  • A leading producer of custom-made infusion solutions for cytostatic drugs and parenteral nutrition

Vision & Outlook

Support continued accelerated growth, both organically and through acquisitions

Drive further growth in homecare and adjacent healthcare segments, as well as by developing new business areas

Highlights & Updates

  • Launch of new digital guidance service for home-based patients in Germany during the corona pandemic with helpful videos and hygiene tips
ghd-corporate logo.png

SECTOR

Healthcare

REVENUES 2021

EUR 585 million

EMPLOYEES

2,365

OWNERSHIP

Fund VIII

HEAD OFFICE

Germany

INVESTMENT DATE

2014

MANAGEMENT

Prof. Dr. Christian Schmidt

CEO

Matthias Born

CFO

RESPONSIBLE ADVISORS

Joakim Lundvall

Partner, Head of Nordic Capital Evolution | Co-head of DACH

Rainer Lenhard

Partner | Co-Head of DACH